Kurashiki, Japan

Yukio Suzuki

This inventor holds 1 USPTO granted patent. Top assignee: Hayashibara Biochemical Laboratories, Inc.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukio Suzuki. Retrieved from https://idiyas.com/inventor/yukio-suzuki-reus7pv8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yukio Suzuki

Introduction

Yukio Suzuki is a notable inventor based in Kurashiki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of antibacterial agents. His work is characterized by a focus on safety and efficacy in pharmaceutical applications.

Latest Patents

Yukio Suzuki holds a patent for "Alpha-D-glycosyl kasugamycin, its preparation, and antibacterial agent." This innovative substance is an α-D-glycosyl kasugamycin, which is designed to be highly safe and easily hydrolyzed by α-glucosidase. The resulting compound exhibits the physiological activities inherent to kasugamycin, making it a valuable addition to antibacterial treatments. He has 1 patent to his name.

Career Highlights

Suzuki is currently employed at Hayashibara Biochemical Laboratories, Inc., where he continues to advance his research in biochemistry. His work has implications for the development of new antibacterial agents that are both effective and safe for use.

Collaborations

Some of his notable coworkers include Koutarou Muroyama and Kei Suzuki. Their collaborative efforts contribute to the innovative research environment at Hayashibara Biochemical Laboratories, Inc.

Conclusion

Yukio Suzuki's contributions to the field of biochemistry, particularly through his patent on α-D-glycosyl kasugamycin, highlight his commitment to innovation in antibacterial agents. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…